[1] S MB, Zaragoza R. Critical overview of clinical guidelines relating to invasive fungal infections [J]. Int J Antimicrob Agents, 2008, 32 (Supp12):S155-S159. [2] 李 真, 左绪磊. 侵袭性念珠菌病的实验室诊断研究进展[J]. 检验医学, 2007,22(1):102-104. [3] Zaragoza R, Pemn J, Quinds G, et al. Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients [J]. Clin Microbiol Infect, 2009, 15(6):592-595. [4] Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the(1->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans [J]. Clin Infect Dis, 2005, 41(5): 654-659. [5] 武建国. 关注侵袭性真菌感染的实验诊断[J]. 临床检验杂志, 2010, 28 (2):87-89. [6] 钱丽洁, 朱 敏, 李 莉, 等. 系统性白念珠菌病患者血清中芽管抗体的检测 [J]. 中华皮肤科杂志, 2006, 39(8):460-462. [7] Kohno S, Mitsutake K, Maesaki S, et al. An evaluation of serodiagnostic tests in patients with candidemia: beta-glucan, mannan, candida antigen by Cand-Tec and D-arabinitol [J]. Microbiol Immunol, 1993, 37(3): 207-212. [8] Kondori N, Edebo L, Mattsby-Baltzer I. Circulating beta (1-3) glucan and immunoglobulin G subclass antibodies to Candida albicans cell wall antigens in patients with systemic candidiasis [J]. Clin Diagn Lab Immunol, 2004, 11(2): 344-350. [9] Koo S, Bryar JM, Paqe JH, et al. Diagnostic performance of the (1→3)-beta-D-glucan assay for invasive fungal disease [J]. Clin Infect Dis, 2009, 49(11):1650-1659. [10] Quindós G, Moragues MD, Pontón J. Is there a role for antibody testing in the diagnosis of invasive candidiasis [J]. Rev Iberoam Micol, 2004,21(1):10-14. [11] García-Ruíz JC, del Carmen Arilla M, Regúlez P, et al. Detection of antibodies to Candida albicans germ tubes for the diagnosis and therapeutic monitoring of invasive candidiasis in patients with hematologic malignancies [J]. J Clin Microbiol, 1997, 35(12): 3284-3287. [12] 孔小祥, 李芳秋, 王仕钦, 等. 用动物模型评估抗烯醇化酶抗体测定对系统性白念珠菌病的诊断价值 [J]. 临床检验杂志, 2011, 29(1):69-71. [13] 孔小祥, 李芳秋, 王仕钦, 等. 抗烯醇化酶抗体检测对侵袭性念珠菌病的诊断价值[J]. 临床检验杂志, 2011, 29(6):413-415. |